Tech Company Financing Transactions
Halo Labs Funding Round
Agilent Technologies, BioAdvance Ventures and BroadOak Capital Partners participated in a $6 million funding round for Halo Labs. The round was announced on 7/11/2022.
Transaction Overview
Company Name
Announced On
7/11/2022
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Undisclosed
Investors
Agilent Technologies (Lead Investor)
Research Corporation Technologies (Chad Souvignier)
Proceeds Purpose
This new funding will be used for continued commercialization of Halo Labs' Aura� platform, increasing manufacturing capacity and developing innovative new products to meet the current and new needs of pharmaceutical researchers.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1828 El Camino Real 703
Burlingame, CA 94010
USA
Burlingame, CA 94010
USA
Phone
Website
Email Address
Overview
Halo Labs (formerly Optofluidics) is a venture backed scientific instrumentation company that commercializes high throughput biopharmaceutical quality control tools using the latest optics, image processing and microfluidics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Wicke
Chief Scientific Officer
Bernardo Cordovez
Controller
Cristina Pons
VP - Engineering
Spencer Borg
VP - Manufacturing
Paul Davy
VP - Marketing
Renee Tobias
VP - Regulatory Affairs
Bettina Heidecker
VP - Sales
Rick Gordon
Browse more venture capital transactions:
Prev: 7/11/2022: Paladin Cloud venture capital transaction
Next: 7/11/2022: Inspirna venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs